about
Identification of a specifically expressed modified form of novel PSP-94 protein in the secretion of benign prostatic hyperplasiacDNA, genomic cloning, and gene expression analysis of mouse PSP94 (prostate secretory protein of 94 amino acids).Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in miceVasorelaxant effects of cardamonin and alpinetin from Alpinia henryi K. Schum.The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice.Estrogen-related receptor α decreases RHOA stability to induce orientated cell migration.Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells.Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.1,25-Dihydroxyvitamin D3 suppresses gastric cancer cell growth through VDR- and mutant p53-mediated induction of p21.The emerging roles of orphan nuclear receptors in prostate cancer.Coadministrating luteolin minimizes the side effects of the aromatase inhibitor letrozole.Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.Assessing the effect of food mycotoxins on aromatase by using a cell-based system.ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation.17-Beta-estradiol induces neoplastic transformation in prostatic epithelial cells.Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators.Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels.Mouse PSP94 expression is prostate tissue-specific as demonstrated by a comparison of multiple antibodies against recombinant proteins.Roles of cyclic AMP and Ca2+-activated K+ channels in endothelium-independent relaxation by urocortin in the rat coronary artery.The nucleus of HeLa cells contains tubular structures for Ca2+ signaling with the involvement of mitochondria.Raloxifene relaxes rat cerebral arteries in vitro and inhibits L-type voltage-sensitive Ca2+ channels.Estrogen and tamoxifen modulate cerebrovascular tone in ovariectomized female rats.FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer.Differential effects of estrogen and progesterone on potassium channels expressed in Xenopus oocytes.Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.Orphan nuclear receptor TLX functions as a potent suppressor of oncogene-induced senescence in prostate cancer via its transcriptional co-regulation of the CDKN1A (p21(WAF1) (/) (CIP1) ) and SIRT1 genes.Characterization of the T-cell receptor repertoire by deep T cell receptor sequencing in tissues from patients with prostate cancer.Nuclear receptor LRH-1 functions to promote castration-resistant growth of prostate cancer via its promotion of intratumoral androgen biosynthesis.Contribution of nitric oxide and K+ channel activation to vasorelaxation of isolated rat aorta induced by procaine.The nuclear tubular invaginations are dynamic structures inside the nucleus of HeLa cells.Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysisDevelopment of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cellsSerum C-peptide concentration and prostate cancer: A meta-analysis of observational studiesLRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis
P50
Q28198937-08A12762-B859-4773-9976-054A23B6B1FAQ30635905-4F849000-091B-4831-BA9B-CFA427C25922Q33805554-AA6F38D2-29AB-48FD-BD2B-C748F4A8A83EQ33945388-3FC75446-E7C3-4929-8A2E-61C679362AE6Q34243734-2F02588D-6539-48D2-B93E-9AFA7F031666Q34408834-7BC71F60-3585-48AD-B40D-57630974AB8BQ37200457-26FD0BCC-AE8C-467C-95EA-48CF4706AD95Q37622198-FECB69C3-FCCE-4BDC-8606-9ECB32208516Q38705153-32F648B6-BA64-40CE-88F7-037E1C7FD106Q38855511-75317452-92FA-4F68-B046-522D0D4A26EFQ38964602-E825A7D8-CF24-428D-94A6-69A7015D72C1Q38971352-FFB38FCB-C6D0-40AC-AC5E-9248C797B782Q39025378-4AEDAAD7-4788-4B04-B030-6596C2884712Q39034345-D895E914-E69B-42C0-B54E-8C798DA8C1F4Q39275054-B771AE1D-A729-4CA9-9852-FB8FACA99BFBQ39585749-47C1879F-42E6-45C3-BBD5-F852F05A60C6Q39867854-279C497A-7083-419B-8B95-DB37A0A7FC75Q39907583-6C6629B0-D0DA-4453-AFF0-C7743B36CD81Q40131269-5C05F2DC-464F-4688-8A56-D1FBD24B4646Q40209231-A48EF350-B194-49B8-8B36-CB4FBFD2032DQ43263860-DC64A281-18F5-47F9-8368-4C413D31E89FQ44343262-DA7F6C38-B15F-4087-8FBF-DE53D2A7710FQ44346328-24BDADFB-0779-4C44-B045-F559F8A8F4F5Q44555495-1EF61F1E-0CA8-4F7B-A9C1-B69BE7E1273AQ44905004-57FF7BCD-8E08-4432-B44C-3421B8AC450AQ44907787-48C34A09-3C53-4F1E-94D7-D32F44081BE5Q46573682-05BB4BDB-2A9C-4190-80A9-398344F4A0D5Q46858802-A16D8DD0-B742-406A-8E1E-40DD4920E7BFQ47637540-A917A097-61CF-44D8-8810-960C94BD6821Q48391809-2B8A2DF2-EE81-4615-AD12-BA2044F6FEF1Q49312630-2399C5FF-91F4-4E55-8AE8-3A5D89E3EAD9Q50036868-3E819770-8C03-4582-A7C1-437612DA5C88Q50519845-974087A0-61EE-42E9-9EE8-68AE60A8B43EQ50725242-3BAC9C22-7D1B-4A38-A95F-F150E28AE5ACQ52647907-2F6545B9-60A4-4741-BADF-B5334E967209Q57109751-DF3CBBBD-F0D7-4C31-9AC0-8464368BF2EEQ58695296-5B858974-4F65-4CFE-9AD7-F8E78309DDACQ58802108-448960C4-9F03-4E35-929E-1A0B3B841B84Q58806320-7F5832C8-F38D-4F5C-BF03-4DE58AAA88D9Q64070884-A3D1F11C-650D-4413-BB03-5C661C62A8F9
P50
description
researcher ORCID ID = 0000-0003-0567-2052
@en
name
Franky Leung Chan
@ast
Franky Leung Chan
@en
Franky Leung Chan
@es
Franky Leung Chan
@nl
type
label
Franky Leung Chan
@ast
Franky Leung Chan
@en
Franky Leung Chan
@es
Franky Leung Chan
@nl
prefLabel
Franky Leung Chan
@ast
Franky Leung Chan
@en
Franky Leung Chan
@es
Franky Leung Chan
@nl
P31
P496
0000-0003-0567-2052